Source: Annual Congress 2002 - COPD - Drug therapy 1
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Stockley, E. A. Davis, S. Sondhi, L. Rice, on Behalf of an International Study Group (Birmingham, United Kingdom; Research Triangle Park, United States Of America). Salmeterol provides sustained health status improvement over 12 months in patients with COPD. Eur Respir J 2002; 20: Suppl. 38, 1567

Member's Comments

No comment yet.

Related content which might interest you: Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 A disease specific self-management intervention reduces hospital utilization in patients with COPD: a sustained effect at 2 years Source: Eur Respir J 2003; 22: Suppl. 45, 347s Year: 2003 Breathing training exercises result in persistent improvements in asthma health status at 12 months Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 Improvement of dyspnoea following of six months treatment with tiotropium but not with salmeterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001 An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Source: Eur Respir J 2002; 19: 209-216 Year: 2002 Six months and one year follow up of COPD patients who had oral nutritional supplement therapy as a part of pulmonary rehabilitation program Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Indacaterol provides effective bronchodilation in patients with COPD irrespective of age Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 QVA149 administered once daily provides significant improvements in lung function over 1 year in patients with COPD: The ENLIGHTEN study Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 Impact of fatigue improvement after pulmonary rehabilitation education on the long-term prognosis of patients with COPD Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 430s Year: 2003 Does daily SMS increase adherence to asthma treatment? A three months follow-up study Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009